Zyprexa and Paraesthesia oral - a phase IV clinical study of FDA data

Summary:

Paraesthesia oral is reported as a side effect among people who take Zyprexa (olanzapine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Zoloft, and have Mania.

The phase IV clinical study analyzes which people have Paraesthesia oral when taking Zyprexa. It is created by eHealthMe based on reports of 63,412 people who have side effects when taking Zyprexa from the FDA, and is updated regularly.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,724 Zyprexa users. Check the latest studies of Zyprexa.

What is Paraesthesia oral?

Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect) is found to be associated with 976 drugs and 973 conditions by eHealthMe. Check the latest studies of Paraesthesia oral.

On Jul, 06, 2026

63,412 people reported to have side effects when taking Zyprexa.
Among them, 23 people (0.04%) have Paraesthesia oral.

Among these 23 people:

How long have people been on Zyprexa when they have Paraesthesia oral? *

What is the gender of people who have Paraesthesia oral when taking Zyprexa? *

female: 56.52 %
male: 43.48 %

What is the age of people who have Paraesthesia oral when taking Zyprexa? *

What are other drugs people take besides Zyprexa? *

What are other side effects people have besides Paraesthesia oral? *

Drug Ineffective: 5 people, 21.74%
Hypoaesthesia Oral (reduced sense of touch or sensation in mouth): 5 people, 21.74%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 21.74%
Weight Increased: 4 people, 17.39%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 17.39%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 17.39%
Nausea (feeling of having an urge to vomit): 4 people, 17.39%
Dizziness: 4 people, 17.39%
Visual Disturbance: 4 people, 17.39%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 13.04%

What are the existing conditions these people have? *

Mania (a state of abnormally elevated or irritable mood): 4 people, 17.39%
Agitation (state of anxiety or nervous excitement): 3 people, 13.04%
Psychotic Disorder: 2 people, 8.70%
Mood Swings (an extreme or rapid change in mood): 2 people, 8.70%
Fatigue (feeling of tiredness): 2 people, 8.70%
Affective Disorder (mental disorder): 2 people, 8.70%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 4.35%
Sleep Disorder: 1 person, 4.35%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.35%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Zyprexa and have Paraesthesia oral?

- Check whether Paraesthesia oral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zyprexa:

Zyprexa (64,724 reports)

Browse all side effects of Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraesthesia oral:

Paraesthesia oral (976 drugs)

Browse all the conditions that are associated with Paraesthesia oral:

Paraesthesia oral (973 conditions)

Related publications that referenced our studies

Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.